CLSN News and Press, Celsion Corporation From 02/22/21

ReTo Eco-Solutions (RETO) +132%.ATIF Holdings Limited (ATIF) +70% on establishing SPAC department to plan establishment of SPAC.Xcel Brands  (XELB) +52%.Celsion Corporation (CLSN) +48% after receiving FDA fast track designation for GEN-1.Can-Fite BioPharma (CANF) +28% on p...

The FDA has granted Fast Track designation to Celsion's (CLSN) GEN-1, an immunotherapy in phase 2 for advanced ovarian cancer.The phase 2 study, known as OVATION 2, of the DNA-mediated interleukin-12 (IL-12) candidate is combining GEN-1 with standard-of-care neoadjuvant chemotherapy in newly ...

Celsion’s Commitment to Promoting Immune System Solutions to Fight Life-Threatening Diseases Granted an Accelerated Development Pathway Designation Provides Potential for an Expedited Regulatory Review. LAWRENCEVILLE, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) -- ...

These Were The Top Performing Penny Stocks So Far In Q1 2021 Each quarter we update our list of penny stocks with new names. These include companies listed on major exchanges like the Nasdaq and New York Stock Exchange. The list of penny stock also includes names from the OTCQX, OTC...

LAWRENCEVILLE, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that Jeffrey Church, Celsion’s Executive Vice President and Chief Financial Officer, will present at NobleConXV - Noble Capital Markets...

NEW YORK, Oct. 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of The ExOne Company (NASDAQ:XONE), Switch, Inc. (NYSE:SWCH), Monotype Im...